What is the appropriate dosage of Keflex (cefazolin) for an adult with a skin infection of the knee?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Appropriate Keflex Dosage for Skin Infection of the Knee

For an adult with a skin infection of the knee, the appropriate Keflex (cephalexin) dosage is 500 mg orally four times daily (every 6 hours), or alternatively 500 mg every 12 hours for uncomplicated skin and soft tissue infections. 1

Dosing Algorithm

The FDA-approved dosing for Keflex in skin and soft tissue infections follows this framework 1:

Standard Adult Dosing

  • Mild to moderate infections: 250 mg every 6 hours OR 500 mg every 12 hours
  • More severe infections or less susceptible organisms: 500 mg every 6 hours (up to 4 g daily maximum)
  • Treatment duration: Typically 7-14 days depending on clinical response

Key Dosing Considerations

For uncomplicated skin infections (cellulitis without systemic signs), the 500 mg every 12 hours regimen is FDA-approved and clinically validated 1. Research confirms this dosing is non-inferior to parenteral therapy for mild-moderate infections 2.

For more severe presentations (extensive involvement, systemic symptoms, or concern for deeper infection), increase to 500 mg every 6 hours. The IDSA guidelines support cephalexin for non-purulent skin infections at standard dosing 3.

Important Clinical Caveats

When Cephalexin May NOT Be Appropriate

  • MRSA suspected or confirmed: Cephalexin has no reliable activity against MRSA despite some clinical response seen in studies 4. If MRSA is suspected (purulent infection, abscess, prior MRSA history), choose an MRSA-active agent like trimethoprim-sulfamethoxazole, doxycycline, or clindamycin 3.

  • Severe/necrotizing infection: If there are signs of deeper tissue involvement (severe pain disproportionate to findings, systemic toxicity, crepitus, bullae), parenteral therapy with broader coverage is required 3.

  • Failure of initial therapy: If the patient doesn't improve within 48-72 hours, reassess for MRSA, abscess requiring drainage, or alternative diagnosis 3.

Pediatric Dosing

For children, the dose is 25-50 mg/kg/day divided into 3-4 doses, with severe infections requiring up to 100 mg/kg/day 1.

Special Populations

Obese patients (≥120 kg): Recent evidence suggests higher doses may be beneficial, though this applies more to parenteral cefazolin than oral cephalexin 5. Consider 500 mg every 6 hours rather than every 12 hours in significantly obese patients.

Practical Implementation

The 500 mg every 12 hours regimen offers better adherence due to twice-daily dosing compared to four-times-daily regimens, with equivalent efficacy for uncomplicated infections 2, 4. However, for knee infections with significant surrounding cellulitis or concern for deeper involvement, the more conservative 500 mg every 6 hours provides better pharmacodynamic coverage 6.

Bottom line: Start with 500 mg every 6 hours for most knee skin infections to ensure adequate coverage, then consider de-escalation to every 12 hours dosing if the infection is clearly superficial and responding well.

Related Questions

What is the recommended dosing of cephalexin oral suspension for an adult with cellulitis?
What is the recommended cephalexin dosing for cellulitis in adults and children, and how should the dose be adjusted for renal impairment or MRSA risk?
Can cephalexin be given for more than seven days in the treatment of uncomplicated cellulitis?
What is the recommended cefazolin dosing regimen for cellulitis in adults and children, including adjustments for severity, obesity, and renal impairment?
What is the recommended intravenous (IV) dose of Cefazolin for skin and soft tissue infections and abscesses?
In a 65-year-old man with no significant past medical history, a mildly elevated bilirubin of 1.4 mg/dL and a fasting glucose of 105 mg/dL with all other routine labs normal, what is the appropriate management?
Is Luvox (fluvoxamine) a top choice for treating obsessive‑compulsive disorder?
In a 51‑year‑old woman with a history of Lyme disease, recurrent leukocytosis, acute kidney injury (with renal causes excluded) and negative workup for lupus and Sjögren’s syndrome, who now presents with abdominal bloating, burning abdominal pain, urethral burning unrelated to urination, and a clear thick vaginal discharge, what is the appropriate diagnostic workup and management?
A patient on Depakote (valproic acid) 1000 mg who missed doses for a few days due to moving wants to restart the previous dose; should a serum valproic‑acid level be obtained before resuming the prior dose?
What are the differential diagnoses for extremely foul‑smelling flatulence with marked abdominal bloating?
Is a blood glucose level of 48 mg/dL considered dangerous (hypoglycemia)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.